This article summarises the position reached with the GLP-1 RAs and reviews the developing field of unimolecular co-agonists that act not only on the GLP-1 receptor, but on other receptors, notably glucose-dependent insulotropic polypeptide (GIP) and glucagon receptors, with the aim of further improving glycaemic control and weight reduction
ahajournals.org (Atypon), Franchini, Massimo, et al
Look for ingredients like ceramides, hyaluronic acid, and squalanethey help seal in moisture, reduce water loss, and restore balance after sun stress
While yeast infections are generally not medical emergencies, certain situations require prompt professional evaluation to ensure appropriate diagnosis and treatment
Studies suggest side effects can occur in 40-70% of patients receiving a GLP-1 RA
In a study published in JAMA Psychiatry in February 2025 that included 48 patients with AUD, researchers found low-dose weekly injections of semaglutide significantly reduced alcohol cravings and nicotine use compared with placebo